Dr. Aaron Schwartz
Dr. Aaron Schwartz has been a member of the company’s board of directors since November 2014. He had a distinguished career at Teva Pharmaceuticals spanning nearly four decades, where he served in various senior executive positions until his retirement in 2011, with his most recent role being Vice President, Head of Teva Innovative Ventures. From January 2013 to November 2017, he served as a member of the board of directors of Alcobra Ltd. Dr. Schwartz is currently Chairman of the board of BiolineRx Ltd., and a member of the board of directors of Barcode Ltd. Dr. Schwartz received a PhD in organic chemistry from Weizmann Institute of Science, and a PhD in the history and philosophy of science from The Hebrew University of Jerusalem. He also received an MSc in organic chemistry from Technion, and a BSc in chemistry and physics from The Hebrew University of Jerusalem.